What is the recommended dose of Macrobid (nitrofurantoin monohydrate) for an adult woman with uncomplicated acute cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Dosing for Acute Cystitis

For uncomplicated acute cystitis in adult women, prescribe Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg orally twice daily for 5 days. 1, 2

Standard Dosing Regimen

  • The 5-day course is the optimal duration, achieving clinical cure rates of 84-90% and bacterial cure rates of 92% at early follow-up (5-9 days post-treatment). 1
  • At 30-day follow-up, clinical cure rates remain robust at 84%, demonstrating sustained efficacy. 1
  • This regimen has comparable efficacy to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days when local resistance is low. 3, 2

Alternative Duration Option

  • A 7-day course (100 mg twice daily) is acceptable if you prefer a longer duration, with clinical cure rates of 89-93% and bacterial cure rates of 86%. 1
  • The 7-day regimen shows equivalent efficacy to ciprofloxacin and trimethoprim-sulfamethoxazole when comparing similar duration courses. 1
  • Avoid 3-day regimens (100 mg four times daily) due to inferior efficacy, with only 88% clinical cure and 74% bacterial cure rates. 1

Critical Contraindications

  • Do not use nitrofurantoin if creatinine clearance is <60 mL/min, as inadequate urinary drug concentrations prevent bactericidal activity and increase toxicity risk. 1
  • Do not use if early pyelonephritis is suspected, as nitrofurantoin does not achieve adequate tissue concentrations for upper tract infections. 1, 2

Common Pitfalls to Avoid

  • Prescribing excessive duration: Most prescriptions in primary care are longer than guideline recommendations (73% of nitrofurantoin prescriptions exceed recommended duration), which increases adverse effects without additional benefit. 4
  • Using fluoroquinolones as first-line: Despite their high efficacy, fluoroquinolones should be reserved for more invasive infections due to collateral damage and resistance concerns. 3, 5

Expected Adverse Effects

  • Nausea and headache are the most common side effects, occurring in 5.6-34% of patients depending on the study. 1, 2
  • Advise adequate hydration during treatment to prevent crystal formation. 2

When to Choose Alternative First-Line Agents

  • If CrCl <60 mL/min: Switch to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local E. coli resistance <20%) or fosfomycin 3 g single dose. 1
  • If patient has sulfa allergy and normal renal function: Fosfomycin 3 g single dose is an alternative, though it has slightly lower efficacy (90% vs 95% clinical cure for nitrofurantoin). 1
  • If local trimethoprim-sulfamethoxazole resistance is <20% and patient has no contraindications: Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days is an equivalent alternative. 3, 1

References

Guideline

Nitrofurantoin Macrocrystals Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.